BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-288@pharmaconomics
DTSTAMP:20260707T015304Z
DTSTART;VALUE=DATE:20261223
DTEND;VALUE=DATE:20261224
SUMMARY:GILD PDUFA — anito-cel
DESCRIPTION:The FDA's approval decision on anito-cel for multiple myeloma is due Dec 23\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/882095/000110465926018314/tm267044d1_ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/288
URL:https://pharmaconomics.com/e/288
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:GILD catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR